|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.00 INR | -0.36% |
|
+9.89% | +73.88% |
| May. 21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| May. 20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.69B 69.41M 60.84M 56.24M 51.72M 97.59M 99.16M 672M 264M 3.28B 261M 255M 11.28B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.56B 78.36M 68.69M 63.49M 58.39M 110M 112M 759M 298M 3.7B 294M 288M 12.74B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.79% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -0.36% | ||
| 1 week | +9.89% | ||
| Current month | +0.56% | ||
| 1 month | +4.65% | ||
| 3 months | +56.80% | ||
| 6 months | +59.48% | ||
| Current year | +73.88% |
| 1 week | 118.3 | 125.5 | |
| 1 month | 111.5 | 133.95 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.36% | +9.89% | +5.13% | +2.42% | 69.76M | ||
| +1.23% | +1.08% | +15.52% | +80.84% | 48.15B | ||
| -0.23% | -1.65% | +67.15% | +109.36% | 35.59B | ||
| +1.61% | +0.15% | -2.75% | +39.18% | 11.9B | ||
| +0.46% | -0.16% | +17.85% | +89.14% | 11.85B | ||
| +0.93% | +2.87% | +34.92% | +137.61% | 9.31B | ||
| +3.37% | -0.10% | +51.64% | -4.77% | 7.02B | ||
| -0.42% | +0.25% | +16.05% | +34.73% | 6.91B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| +0.18% | -1.90% | +0.63% | +211.00% | 6.55B | ||
| Average | +0.68% | +0.48% | +22.91% | +77.72% | 14.41B | |
| Weighted average by Cap. | +0.74% | -0.67% | +29.99% | +88.66% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.32M 34.46M 31.85M 29.3M 55.28M 56.16M 381M 149M 1.86B 148M 144M 6.39B | 3.74B 38.83M 34.03M 31.46M 28.93M 54.59M 55.46M 376M 147M 1.83B 146M 143M 6.31B |
| Net income | 122M 1.26M 1.11M 1.02M 940K 1.77M 1.8M 12.22M 4.79M 59.52M 4.74M 4.63M 205M | 58.38M 605K 531K 491K 451K 851K 865K 5.87M 2.3M 28.57M 2.27M 2.22M 98.42M |
| Net Debt | 1.16B 12M 10.52M 9.73M 8.95M 16.88M 17.15M 116M 45.59M 566M 45.08M 44.09M 1.95B | 863M 8.95M 7.84M 7.25M 6.67M 12.58M 12.79M 86.71M 33.99M 422M 33.61M 32.87M 1.45B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | ₹125.00 | -0.36% | 2,296 |
| 26-07-17 | ₹125.45 | +1.95% | 8,530 |
| 26-07-16 | ₹123.05 | +1.99% | 3,069 |
| 26-07-15 | ₹120.65 | +1.99% | 5,681 |
| 26-07-14 | ₹118.30 | +1.98% | 2,646 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















